These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 22722457)
1. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy. Su J; Zhu S; Liu Z; Jing S; Shen W; Li J Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457 [TBL] [Abstract][Full Text] [Related]
2. A study of elderly patients with limited-stage small-cell lung cancer after combined chemoradiotherapy. Su J; Zhu S; Liu Z; Li J; Shen W; Li R Am J Ther; 2014; 21(5):371-6. PubMed ID: 22975663 [TBL] [Abstract][Full Text] [Related]
3. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer. Sas-Korczynska B; Sokolowski A; Korzeniowski S Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659 [TBL] [Abstract][Full Text] [Related]
4. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response. Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447 [TBL] [Abstract][Full Text] [Related]
5. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study. El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung]. Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
8. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma. Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens. Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624 [TBL] [Abstract][Full Text] [Related]
10. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy. Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L J BUON; 2015; 20(1):146-57. PubMed ID: 25778310 [TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study. Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518 [TBL] [Abstract][Full Text] [Related]
12. Small-cell lung cancer: prognostic factors and changing treatment over 15 years. Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695 [TBL] [Abstract][Full Text] [Related]
13. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491 [TBL] [Abstract][Full Text] [Related]
14. Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial. Sheikh H; Colaco R; Lorigan P; Blackhall F; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C Lung Cancer; 2011 Oct; 74(1):75-9. PubMed ID: 21353720 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of downstaging in patients with limited-disease small-cell lung cancer. Go SI; Keam B; Kim TM; Lee SH; Kim DW; Kim HJ; Wu HG; Chung DH; Heo DS Clin Lung Cancer; 2014 Mar; 15(2):e1-6. PubMed ID: 24356090 [TBL] [Abstract][Full Text] [Related]
17. [Combined modality therapy for small cell lung cancer patient with limited stage disease]. Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803 [TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of superior sulcus tumors: results and prognostic factors. Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311 [TBL] [Abstract][Full Text] [Related]
19. Induction concurrent chemoradiotherapy compared with induction radiotherapy for superior sulcus non-small cell lung cancer: a retrospective study. Li J; Dai CH; Shi SB; Bao QL; Yu LC; Wu JR Asia Pac J Clin Oncol; 2010 Mar; 6(1):57-65. PubMed ID: 20398039 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of treatment outcomes in two patient cohorts (2004-2005 and 2007-2008) with limited and extensive disease small-cell lung cancer]. Hermes A; Waschki B; Gatzemeier U; Reck M Pneumologie; 2011 Apr; 65(4):203-7. PubMed ID: 21267814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]